A concise, evidence-based one-pager summarizing the rapid growth in peer-reviewed kratom research. It covers 300+ publications since 2022, 1,000+ cataloged papers, 18 human clinical studies, major NIDA-supported work, key safety and pharmacokinetic findings, and the recent NIH IND for purified mitragynine. The document shows why science supports preserving responsible access to natural kratom leaf while targeting concentrated synthetic products like 7-OH.